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ABSTRACT 
 
 
Smoking has devastating effects on general health, including the outcome after 
surgery. There were three main objectives in this thesis. Firstly, to investigate the 
effect of smoking on complications after orthopaedic surgery. Secondly, to evaluate 
whether the negative effect of smoking on the complication rate after acute 
orthopaedic surgery was reversible after smoking cessation therapy and thirdly, to 
evaluate whether the administered smoking cessation therapy had any long-lasting 
effect on the smoking abstinence rate.  
 
Study I included 906 patients with surgically treated ankle fractures. Background data 
were collected from patient charts and the outcome regarding postoperative 
complications was recorded prospectively in a clinical audit. Studies II and III were 
based on the same population from a single-blinded, randomized, controlled, clinical, 
multicenter trial at three hospitals in Stockholm, Sweden. We randomized 105 daily 
smokers with an acute fracture of a lower or upper extremity requiring acute surgical 
procedures into an intervention group (smoking cessation therapy) or into a control 
group. The primary outcome in Study II was any complication occurring, as 
predefined in the study protocol, within 6–12 weeks. The outcome in Study III was 
medium- and long-term successful smoking cessation. In Study IV the background 
data were taken from the SALT cohort in the Swedish Twin Registry. The SALT data 
were then linked to the Swedish Inpatient Registry, identifying 8773 individuals who 
had had orthopaedic surgery and who also had had a complication from that surgery. 
 
In Study I it was shown that 30.1% of the smokers had a postoperative complication 
compared to 20.3% of the non-smokers (OR 1.9, CI: 1.3–2.8, p=0.005). In study II 
the administered smoking cessation therapy significantly reduced the number of 
postoperative complications (p=0.048). Study III showed that the administered 
smoking cessation therapy had a significant effect during the first 6–12 weeks, but 
not after one year. Study IV demonstrated that smokers had a significantly increased 
risk of developing complications requiring inpatient care; among the smokers, 14.9%, 
compared to 11.4% of the non-smokers, had such a complication (HR 1.27, CI: 1.10–
1.48, p=0.002).   
 
Smoking is a strong and significant factor associated with development of 
postoperative complications. Smoking cessation intervention program during the first 
six weeks after acute fracture surgery decreases the risk of postoperative 
complications. Smoking patients in need of both acute and elective orthopaedic 
surgery should be offered an intensive smoking cessation programme. 
 
